JAKKS Pacific (JAKK) , Green Dot (GDOT) , Signet Jewelers (SIG) , Gibraltar Industries (ROCK) and PCB Bancorp (PCB) are some companies with low price-to-sales ratios and the potential to offer higher returns. What is the Price-to-Sales Ratio? While a loss-making company with a negative price-to-earnings ratio falls out of investor favor, its price-to- sales can indicate the hidden strength of the business. This underrated ratio is also used to identify a recovery situation or ensure a company's growth is no ...

Key Takeaways Oceaneering International, Inc. (OII) recently announced a major win for its Aerospace and Defense Technologies (ADTech) segment, a $33 million single-award fixed-price IDIQ contract to deliver critical support equipment for Virginia Class Submarines. Awarded by the Naval Surface Warfare Center Philadelphia Division ("NSWCPD"), this strategic contract sets Oceaneering's continued position as a trusted partner in the defense sector and reflects its advanced engineering capabilities in underwate ...

Analyst's Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or a ...

Core Viewpoint - GeneDx Holdings Corp. (WGS) shares experienced a significant increase of 19% in the last trading session, closing at $79.71, driven by strong trading volume and investor optimism regarding its strategic collaboration with Galatea Bio [1][2]. Company Performance - GeneDx is expected to report quarterly earnings of $0.09 per share, reflecting a year-over-year increase of 181.8%. Revenue projections stand at $84.7 million, which is a 20.1% increase compared to the same quarter last year [3]. - The consensus EPS estimate for GeneDx has remained unchanged over the past 30 days, indicating that stock price movements may not sustain without trends in earnings estimate revisions [4]. Industry Context - GeneDx operates within the Zacks Medical Services industry, where another company, Progyny (PGNY), closed the last trading session down by 0.9% at $20.79, with a monthly return of 2.2% [4]. - Progyny's consensus EPS estimate for its upcoming report is $0.42, which represents a decrease of 2.3% from the previous year, and it also holds a Zacks Rank of 3 (Hold) [5].

Core Insights - The geopolitical conflict in the Middle East, particularly between Israel and Iran, has escalated with the U.S. entering the war, which may create opportunities for defense and energy sector stocks [1][2] Company Overview - C3.ai Inc. is a mid-cap enterprise AI software provider specializing in applications such as predictive maintenance and generative AI tools [2] - The company has established partnerships with major cloud providers including Microsoft, Alphabet, and Amazon [5] Positive Catalysts - In FY 2025, C3.ai secured over 30% of its contracts from government entities, notably the U.S. Air Force, which extended its contract in May [3][9] - The company generated more than 20% of its FY 2025 bookings from oil and energy companies, with significant contracts from Baker Hughes, Exxon Mobil, and Shell [4][9] Market Position and Competition - C3.ai is positioned as a pure-play enterprise AI software company, focusing on actionable AI deployment rather than hardware [6] - The competitive landscape includes notable players like Palantir Technologies and Snowflake, with C3.ai facing challenges as these competitors evolve their offerings [7] Valuation and Stock Performance - C3.ai's stock price experienced a negative return of 32% year-to-date in 2025, but has recently increased by 3.8% [8] - Brokerage firms project a 27.5% price upside for C3.ai shares in the short term, with a target price range of $18-$50, indicating a potential upside of 113.6% [10][11] Financial Projections - The expected revenue and earnings growth rates for C3.ai are 20.1% and 9.8%, respectively, for the current year ending April 2026 [10] - The Zacks Consensus Estimate for current-year earnings has improved by 21.3% over the last 30 days, with the company delivering positive earnings surprises in the last four quarters [10]

Core Insights - Newmont Corporation (NEM) is strategically reshaping its portfolio by divesting non-core assets to focus on Tier-1 operations, completing its divestiture program in April 2025 with significant cash proceeds [1][2] - The total gross proceeds from divestitures are projected to reach $4.3 billion, which includes $3.8 billion from non-core divestitures and $527 million from other investments [1][7] - The divestments have led to a $1 billion reduction in gross debt and a record first-quarter free cash flow of $1.2 billion, enhancing the company's financial position [2][7] Financial Performance - NEM's shares have increased by 59.8% year to date, outperforming the Zacks Mining – Gold industry's rise of 54.4%, primarily due to a rally in gold prices [6] - The earnings per share (EPS) estimates for NEM indicate a projected growth of 20.1% year over year in 2025, with estimates trending higher over the past 60 days [7][9] Competitive Landscape - Other companies in the industry, such as Barrick Mining Corporation and Kinross Gold Corporation, have also divested non-core assets to focus on Tier-1 operations, indicating a broader trend in the mining sector [4][5] - Barrick has completed several divestitures, including the sale of its 50% interest in the Donlin Gold Project, while Kinross has streamlined its portfolio by selling Russian assets and interests in Ghana [4][5] Valuation Metrics - NEM is currently trading at a forward 12-month earnings multiple of 13.46, which is approximately 3.6% lower than the industry average of 13.96 [8] - The company holds a Value Score of B, reflecting its competitive positioning in the market [8]

The U.S. stock market stumbled near all-time highs last week, prompting investors to review the landscape. With conflicts brewing overseas and economic data beginning to weaken, it might be time to once again focus on income over capital appreciation. One area with both strong growth prospects and dividends is the international banking sector, and today we’ll look at three international bank stocks that could help preserve capital if market conditions break down. Get Banco Santander alerts:The End of U.S. E ...

AmpliTech Group’s 5G Division Receives Follow On Order As Part Of $78M LOI For 5G ORAN Radios From Strategic Open RAN Systems Integrator And Global Deployment Partner Hauppauge, NY, June 24, 2025 – PRISM MediaWire – AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and ...

One of the largest U.S. residential real estate brokerage firms is taking on real estate giant Zillow over "consumer choice." On Monday, real estate brokerage Compass filed a 60-page complaint in Manhattan federal court, claiming that Zillow is improperly refusing to list homes on its site that were first listed elsewhere."The Zillow Ban seeks to ensure that all home listings in this country are steered on to its dominant search platform so Zillow can monetize each home listing and protect its monopoly," th ...

Market Overview - U.S. stock markets faced a setback in 2025 following a significant bull run driven by artificial intelligence in 2023 and 2024, with the Nasdaq Composite rising 43.4% in 2023 and 28.6% in 2024, but only up 0.9% year to date in 2025 [1] Non-Tech Stock Performance - Despite the overall poor performance of the Nasdaq index, several large-cap non-tech stocks have seen substantial gains, with some achieving over 20% returns year to date, indicating potential investment opportunities [2][9] Recommended Stocks - Five non-tech stocks are recommended for investment: Sprouts Farmers Market Inc. (SFM), Royal Gold Inc. (RGLD), Thomson Reuters Corp. (TRI), Woodward Inc. (WWD), and Exelixis Inc. (EXEL), all carrying favorable Zacks Ranks [3][9] Sprouts Farmers Market Inc. (SFM) - SFM, with a Zacks Rank 1, focuses on product innovation, e-commerce, and private label offerings, leading to better-than-expected fourth-quarter 2024 results with year-over-year growth in both revenue and earnings [6] - For 2025, SFM expects net sales to rise between 10.5% and 12.5%, with comparable store sales anticipated to increase by 4.5% to 6.5% [7] - SFM has an expected revenue growth rate of 13.7% and earnings growth rate of 35.5% for the current year, with a 9% improvement in the Zacks Consensus Estimate for earnings over the last 60 days [8] Royal Gold Inc. (RGLD) - RGLD, also with a Zacks Rank 1, benefits from solid streaming agreements and maintains a strong balance sheet, focusing on dividends, debt reduction, and new business opportunities [10] - Current gold prices around $3,400 per ounce, driven by U.S. tariff policies and geopolitical conflicts, are expected to enhance RGLD's results in upcoming quarters [11] - RGLD has an expected revenue growth rate of 24.1% and earnings growth rate of 35.9% for the current year, with a 0.6% improvement in the Zacks Consensus Estimate for earnings over the last 30 days [12] Thomson Reuters Corp. (TRI) - TRI, with a Zacks Rank 2, operates as a content and technology company across various regions and segments, providing value-added information and technology [13][14] - The company has an expected revenue growth rate of 3.2% and earnings growth rate of 4.2% for the current year, with a 1.3% improvement in the Zacks Consensus Estimate for earnings over the last 60 days [14] Woodward Inc. (WWD) - WWD, also with a Zacks Rank 2, benefits from strong demand in its Aerospace and Core Industrial units, with a positive outlook driven by increased defense spending and solid demand for power generation [15][16] - WWD has an expected revenue growth rate of 3.7% and earnings growth rate of 2.1% for the current year, with a 0.3% improvement in the Zacks Consensus Estimate for earnings over the last 30 days [17] Exelixis Inc. (EXEL) - EXEL, with a Zacks Rank 2, reported better-than-expected first-quarter 2025 results, driven by strong demand for its lead drug, Cabometyx, and recent label expansions [18][19] - The company has an expected revenue growth rate of 7.4% and earnings growth rate of 30.5% for the current year, with a 1.6% improvement in the Zacks Consensus Estimate for earnings over the last 30 days [20]